Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shiza Malik, Khalid Muhammad, Sanaa Masood Aslam & Yasir Waheed. (2023) Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV. Expert Review of Anti-infective Therapy 21:4, pages 431-446.
Read now
Read now
Arturo Ciccullo, Gianmaria Baldin, Cristina Putaggio, Simona Di Giambenedetto & Alberto Borghetti. (2021) Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV. Expert Opinion on Drug Safety 20:11, pages 1317-1332.
Read now
Read now
Claudiu T. Supuran, Alessio Nocentini, Elena Yakubova, Nikolay Savchuk, Stanislav Kalinin & Mikhail Krasavin. (2021) Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida®) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1056-1060.
Read now
Read now
David Rial-Crestelo, Adriana Pinto-Martínez & Federico Pulido. (2020) Cabotegravir and rilpivirine for the treatment of HIV. Expert Review of Anti-infective Therapy 18:5, pages 393-404.
Read now
Read now
Articles from other publishers (49)
Yuan Peng, Yanjun Zong, Dongfeng Wang, Junbing Chen, Zhe-Sheng Chen, Fujun Peng & Zhijun Liu. (2023) Current drugs for HIV-1: from challenges to potential in HIV/AIDS. Frontiers in Pharmacology 14.
Crossref
Crossref
Ankit Kumar Singh, Adarsh Kumar, Sahil Arora, Raj Kumar, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul‐Hamid Emwas & Pradeep Kumar. (2023) Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors. Chemical Biology & Drug Design.
Crossref
Crossref
Supattra Rungmaitree, Linda Aurpibul, Brookie M Best, Xiang Li, Meredith G Warshaw, Hong Wan, Nicole H Tobin, Patricia Jumes, Randi Leavitt, Katie McCarthy, Rachel Scheckter, Pradthana Ounchanum, Avy Violari, Hedy Teppler, Havilland Campbell, Chelsea Krotje, Ellen Townley, Jack Moye, Ann J Melvin, Justine Beck, Thucuma Sise, Bill G Kapogiannis, Kathleen George, Patricia Morgan, Yvonne Woolwine-Cunningham, Rebecca Leblanc, Kathleen Trabert, Jeanne Mendell, Carmelita Alvero, Mona Farhad, Sarah Pasyar, Petronella Muresan, Nehali Patel, Adrienne English, Ryan Heince, Sandra Jones, Ellen Cooper, Debra McLaud, Elizabeth McFarland, Shane Curran Hays, Jennifer Dunn, Kacey Navarro, Amanda Robson, Hilda Ndiwani, Ruth Mathiba, Avy Violari, Nastassja Ramsagar, Nuntisa Chotirosniramit, Chintana Khamrong, Jiraporn Chantong, Angkana Srita, Tim R Cressey, Praornsuda Sukrakanchana, Kanyanee Kaewmamuang, Yupawan Thaweesombat, Nirun Vanprapar, Kulkanya Chokephaibulkit, Nantaka Kongstan & Watcharee Lermankul. (2023) Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014. Journal of the Pediatric Infectious Diseases Society.
Crossref
Crossref
Ritika Srivastava, Sunil K. Gupta, Farha Naaz, Parth Sarthi Sen Gupta, Madhu Yadav, Vishal Kumar Singh, Saroj Kumar Panda, Satyaranjan Biswal, Malay Kumar Rana, Satish Kumar Gupta, Dominique Schols & Ramendra K. Singh. (2023) Exploring antiviral potency of N-1 substituted pyrimidines against HIV-1 and other DNA/RNA viruses: Design, synthesis, characterization, ADMET analysis, docking, molecular dynamics and biological activity. Computational Biology and Chemistry 106, pages 107910.
Crossref
Crossref
Giovanni Battista Dell’Isola, Gianluca Dini, Kaleb Logan Culpepper, Katherin Elizabeth Portwood, Pietro Ferrara, Giuseppe Di Cara, Alberto Verrotti & Mauro Lodolo. (2023) Clinical spectrum and currently available treatment of type I interferonopathy Aicardi–Goutières syndrome. World Journal of Pediatrics 19:7, pages 635-643.
Crossref
Crossref
Xiangyi Jiang, Boshi Huang, Waleed A. Zalloum, Chin-Ho Chen, Xiangkai Ji, Zhen Gao, Jiaojiao Dai, Minghui Xie, Dongwei Kang, Erik De Clercq, Christophe Pannecouque, Xinyong Liu & Peng Zhan. (2023) Discovery of novel diarypyrimidine derivatives bearing six-membered non-aromatic heterocycles as potent HIV-1 NNRTIs with improved anti-resistance and drug-like profiles. European Journal of Medicinal Chemistry, pages 115605.
Crossref
Crossref
Lu Chen, Yanjun Zhang, Zhonghua Wang, Huifang Jiang, Jie Xu & Fei Xiong. (2023) Drug Design, Molecular Docking and Molecular Dynamics Simulations of Indole Class HIV‐1 NNRTIs Explored with QSAR and Topomer Search. ChemistrySelect 8:19.
Crossref
Crossref
Xiangyi Jiang, Boshi Huang, Shawn Rumrill, David Pople, Waleed A. Zalloum, Dongwei Kang, Fabao Zhao, Xiangkai Ji, Zhen Gao, Lide Hu, Zhao Wang, Minghui Xie, Erik De Clercq, Francesc X. Ruiz, Eddy Arnold, Christophe Pannecouque, Xinyong Liu & Peng Zhan. (2023) Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors. Communications Chemistry 6:1.
Crossref
Crossref
Francesco Saladini, Federica Giammarino, Franco Maggiolo, Micol Ferrara, Giovanni Cenderello, Benedetto M. Celesia, Ferdinando Martellotta, Vincenzo Spagnuolo, Giulio M. Corbelli, Nicola Gianotti, Maria M. Santoro, Stefano Rusconi, Maurizio Zazzi & Antonella Castagna. (2023) Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry. International Journal of Antimicrobial Agents 61:3, pages 106737.
Crossref
Crossref
Qiqi Bao & Jinming Zhou. (2023) Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1. European Journal of Medicinal Chemistry 250, pages 115188.
Crossref
Crossref
Reshma Kumari, Sandipan Jana, Susmita Patra, Pallab Kanti Haldar, Rudranil Bhowmik, Avishek Mandal, Kumar Anand, Hindol Mazumdar, Md. Adil Shaharyar & Sanmoy Karmakar. 2023. How Synthetic Drugs Work. How Synthetic Drugs Work
447
475
.
Lina Zhang, Fenju Wei, Jiwei Zhang, Chuanfeng Liu, Nerea López-Carrobles, Xinyong Liu, Luis Menéndez-Arias & Peng Zhan. (2022) Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors. European Journal of Medicinal Chemistry 243, pages 114760.
Crossref
Crossref
Siqiniseko S. Ndlovu, Terisha Ghazi & Anil A. Chuturgoon. (2022) The Potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological Complications. Cells 11:19, pages 2981.
Crossref
Crossref
Radheshyam Jena, Sukriti Vishwas, Rajan Kumar, Jaskiran Kaur, Rubiya Khursheed, Monica Gulati, Thakur Gurjeet Singh, B Meenashi Vanathi, Aftab Alam, Bimlesh Kumar, M.V.N.L. Chaitanya, Saurabh Gupta, Poonam Negi, Narendra Kumar Pandey, Shvetank Bhatt, Gaurav Gupta, Dinesh Kumar Chellappan, Brian G. Oliver, Kamal Dua & Sachin Kumar Singh. (2022) Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead. European Journal of Pharmacology 931, pages 175173.
Crossref
Crossref
Shenghua Gao, Yusen Cheng, Shu Song, Letian Song, Fabao Zhao, Shujing Xu, Dongwei Kang, Lin Sun, Ping Gao, Erik De Clercq, Christophe Pannecouque, Xinyong Liu & Peng Zhan. (2022) Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features. European Journal of Medicinal Chemistry 238, pages 114471.
Crossref
Crossref
Richa Dwivedi, Youya Wang, Christopher Kline, Douglas K. Fischer & Zandrea Ambrose. (2022) APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants. Frontiers in Virology 2.
Crossref
Crossref
Tingting Yue, Pan Zhang, Yuantao Hao, Jianmei He, Jun Zheng, Erik De Clercq, Guangdi Li, Yaxiong Huang & Fang Zheng. (2022) Epidemiology and Clinical Outcomes of HIV Infection in South-Central China: A Retrospective Study From 2003 to 2018. Frontiers in Public Health 10.
Crossref
Crossref
Ming-Tain Lai, Meizhen Feng, Min Xu, Winnie Ngo, Tracy L. Diamond, Carey Hwang, Jay A. Grobler, Daria J. Hazuda & Ernest Asante-Appiah. (2022) Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance. Antimicrobial Agents and Chemotherapy 66:5.
Crossref
Crossref
Jelena Popović-Djordjević, Cristina Quispe, Roberta Giordo, Aleksandar Kostić, Jelena S. Katanić Stanković, Patrick Valere Tsouh Fokou, Katya Carbone, Miquel Martorell, Manoj Kumar, Gianfranco Pintus, Javad Sharifi-Rad, Anca Oana Docea & Daniela Calina. (2022) Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. European Journal of Medicinal Chemistry 233, pages 114217.
Crossref
Crossref
Guangdi Li, Yali Wang & Erik De Clercq. (2022) Approved HIV reverse transcriptase inhibitors in the past decade. Acta Pharmaceutica Sinica B 12:4, pages 1567-1590.
Crossref
Crossref
Zhuoqun Sun, Yun Lan, Shujia Liang, Jing Wang, Mingjian Ni, Xia Zhang, Fengting Yu, Meiling Chen, Hanxi Zhang, Liting Yan, Weiping Cai, Guanghua Lan, Ye Ma & Fujie Zhang. (2022) Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014–18. Journal of Antimicrobial Chemotherapy 77:4, pages 1119-1124.
Crossref
Crossref
Zhao Wang, Srinivasulu Cherukupalli, Minghui Xie, Wenbo Wang, Xiangyi Jiang, Ruifang Jia, Christophe Pannecouque, Erik De Clercq, Dongwei Kang, Peng Zhan & Xinyong Liu. (2022) Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry 65:5, pages 3729-3757.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannPeter Lischka. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
277
296
.
Vanaja Kenchappa, Ruoqiong Cao, Vishwanath Venketaraman & Guru V. Betageri. (2022) Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections. Applied Sciences 12:3, pages 1468.
Crossref
Crossref
KV Lalitha, JRaveendra Reddy & Devanna Nayakanti. (2022) A stability indicating novel analytical method for the determination of lamivudine and dolutegravir in bulk and its tablets using reverse phase high-performance liquid chromatography. Asian Journal of Pharmaceutical Research and Health Care 14:4, pages 209.
Crossref
Crossref
Alexander J. Stockdale & Saye Khoo. (2022) Doravirine: its role in HIV treatment. Current Opinion in HIV and AIDS 17:1, pages 4-14.
Crossref
Crossref
Luis Menéndez-Arias & Rafael Delgado. (2022) Update and latest advances in antiretroviral therapy. Trends in Pharmacological Sciences 43:1, pages 16-29.
Crossref
Crossref
Tali Wagner, Neta S. Zuckerman, Tami Halperin, Daniel Chemtob, Itzchak Levy, Daniel Elbirt, Eduardo Shachar, Karen Olshtain-Pops, Hila Elinav, Michal Chowers, Valery Itsomin, Klaris Riesenberg, Marina Wax, Rachel Shirazi, Yael Gozlan, Natasha Matus, Shirley Girshengorn, Rotem Marom, Ella Mendelson, Dan Turner & Orna Mor. (2021) Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010–2018. Viruses 14:1, pages 71.
Crossref
Crossref
Cristian Jianu, Corina Itu-Mureşan, Adriana Violeta Topan, Irina Filipescu, Mihaela Elena Jianu, Carmen Stanca Melincovici, Carmen Mihaela Mihu & Sorana D. Bolboacă. (2021) Continuum of Care UNAIDS Fast-Track Targets Evaluation of Patients Living with Human Immunodeficiency Virus Infection. Healthcare 9:10, pages 1249.
Crossref
Crossref
V. A. Vavilova, E. V. Shekunova, E. A. Jain (Korsakova), V. Yu. Balabanyan, A. A. Ozerov, M. N. Makarova & V. G. Makarov. (2021) EXPERIMENTAL STUDY OF TOXIC PROPERTIES OF VMU-2012-05 DRUG – ORIGINAL NON-NUCLEESIDE INHIBITOR OF HIV-1 REVERSE TRANSCRIPTASE. Pharmacy & Pharmacology 9:3, pages 205-221.
Crossref
Crossref
E. A. Jain (Korsakova), D. V. Demchenko, A. A. Ozerov, M. N. Makarova, V. G. Makarov & V. Yu. Balabanyan. (2021) CHARACTERISATION AND STUDY OF 1- [2- (2-BENZOYLPHENOXY) ETHYL] -6-METHYLURACIL MECHANISM OF ACTION. Pharmacy & Pharmacology 9:2, pages 114-129.
Crossref
Crossref
Bluma G Brenner, Maureen Oliveira, Ruxandra-Ilinca Ibanescu, Jean-Pierre Routy & Réjean Thomas. (2021) Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir. Journal of Antimicrobial Chemotherapy 76:8, pages 2137-2142.
Crossref
Crossref
Li Ding, Chunlin Zhuang & Fener Chen. (2021) Druggability modification strategies of the diarylpyrimidine‐type non‐nucleoside reverse transcriptase inhibitors. Medicinal Research Reviews 41:3, pages 1255-1290.
Crossref
Crossref
Miao Miao, Erik De Clercq & Guangdi Li. (2021) Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective. Biomedicines 9:4, pages 412.
Crossref
Crossref
Maria E. Cilento, Karen A. Kirby & Stefan G. Sarafianos. (2021) Avoiding Drug Resistance in HIV Reverse Transcriptase. Chemical Reviews 121:6, pages 3271-3296.
Crossref
Crossref
Guangdi Li, Ming Xu, Tingting Yue, Weijie Gu & Li Tan. (2021) Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq. Biochemical Pharmacology 185, pages 114485.
Crossref
Crossref
Joseph A. Ippolito, Haichan NiuNicole Bertoletti, Zachary J. CarterShengyan Jin, Krasimir A. Spasov, José A. CisnerosMargarita ValhondoKara J. CutronaKaren S. Anderson & William L. Jorgensen. (2021) Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead. ACS Medicinal Chemistry Letters 12:2, pages 249-255.
Crossref
Crossref
Guangdi Li, Tingting Yue, Pan Zhang, Weijie Gu, Ling-Jie Gao & Li Tan. (2021) Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday. Molecules 26:4, pages 923.
Crossref
Crossref
Da Feng, Xiaofang Zuo, Lanlan Jing, Chin-Ho Chen, Fisayo A. Olotu, Hao Lin, Mahmoud Soliman, Erik De Clercq, Christophe Pannecouque, Kuo-Hsiung Lee, Dongwei Kang, Xinyong Liu & Peng Zhan. (2021) Design, synthesis, and evaluation of “dual-site”-binding diarylpyrimidines targeting both NNIBP and the NNRTI adjacent site of the HIV-1 reverse transcriptase. European Journal of Medicinal Chemistry 211, pages 113063.
Crossref
Crossref
Steven J. Smith, Xue Zhi Zhao, Dario Oliveira Passos, Dmitry Lyumkis, Terrence R. BurkeJr.Jr. & Stephen H. Hughes. (2021) Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs. Viruses 13:2, pages 205.
Crossref
Crossref
Rajpushpa Labh & Rachna Gupta. (2021) Emerging Trends in the Long-Acting Antiretroviral Therapy: Current Status and Therapeutic Challenges. Current HIV Research 19:1, pages 4-13.
Crossref
Crossref
A. A. Kirichenko, D. E. Kireev, A. V. Kravchenko, A. V. Pokrovskaya, U. A. Kuimova, N. V. Sizova, S. O. Mayorova, D. A. Gusev & V. V. Pokrovsky. (2021) Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients. Journal Infectology 12:5, pages 29-39.
Crossref
Crossref
Maria-Lauretta Orji, NnamdiBenson Onyire, JamesOlisaluka Ojukwu & CeciliaOluchukwu Oyim-Elechi. (2021) The outcome of intervention, characteristics, and determinants of treatment failure in HIV-infected adolescents on first-line antiretroviral therapy at a tertiary health institution, in South-east Nigeria. Nigerian Journal of Medicine 30:5, pages 586.
Crossref
Crossref
Young Hyun Shin, Chul Min Park & Cheol-Hee Yoon. (2021) An Overview of Human Immunodeficiency Virus-1 Antiretroviral Drugs: General Principles and Current Status. Infection & Chemotherapy 53:1, pages 29.
Crossref
Crossref
Steven J. Smith, Gary T. Pauly, Katharine Hewlett, Joel P. Schneider & Stephen H. Hughes. (2020) Structure‐based non‐nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants. Chemical Biology & Drug Design 97:1, pages 4-17.
Crossref
Crossref
Luis Menéndez-Arias, Samara Martín-Alonso & Estrella Frutos-Beltrán. 2021. Antiviral Drug Discovery and Development. Antiviral Drug Discovery and Development
31
61
.
Miri Krupkin, Lynnette Nthenya Jackson, Betty Ha & Elisabetta Viani Puglisi. (2020) Advances in understanding the initiation of HIV-1 reverse transcription. Current Opinion in Structural Biology 65, pages 175-183.
Crossref
Crossref
Dongwei Kang, Da Feng, Yanying Sun, Zengjun Fang, Fenju Wei, Erik De Clercq, Christophe Pannecouque, Xinyong Liu & Peng Zhan. (2020) Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. Journal of Medicinal Chemistry 63:9, pages 4837-4848.
Crossref
Crossref
Dongwei Kang, Da Feng, Lanlan Jing, Yanying Sun, Fenju Wei, Xiangyi Jiang, Gaochan Wu, Erik De Clercq, Christophe Pannecouque, Peng Zhan & Xinyong Liu. (2020) In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP. European Journal of Medicinal Chemistry 193, pages 112237.
Crossref
Crossref